Shares of Mira Pharmaceuticals surged 70% after-hours on Wednesday after the company announced new preclinical data showing ...

Findings show oral Mira-55 fully normalized pain and significantly reduced inflammation, supporting IND plans and reinforcing ...

In the brain, there is a delicate interplay of signaling substances and cellular activity. Scientists have now identified another key player within this ensemble. In a laboratory study they found that ...

MIRA Pharmaceuticals (MIRA) announced new preclinical data showing that oral Mira-55 normalized pain and significantly reduced inflammation, ...

Phytocannabinoids in the form of Cannabis plant is widely consumed by humans. Two of the cannabinoid receptors, CB1 and CB2 are the key targets of this endocannabinoid system. While CB1 is widely ...

The discovery of cannabinoid receptors also instigated a quest for selective CB1 and CB2 receptor antagonists, with varying degrees of success so far. This is definitely a field of future research, ...

Assistant Professor Akira Sobue and Professor Koji Yamanaka of the Research Institute of Environmental Medicine and Graduate School of Medicine at Nagoya University in Japan have reported a potential ...

New research suggests an avenue for developing treatments for chronic pain that harness the medicinal properties of cannabis while minimizing the threat of addiction. Therapeutics that target the ...

According to the Journal of American Medicine, more than one-third of US Adults are considered obese. The annual medical cost associated with obesity is estimated to be $147 billion which is $1,429 ...